Image courtesy of Cephasonics
November 12, 2015 — Cephasonics announced that it has received CE mark approval for its cQuest Cicada subsystem, a 64-channel ultrasound front-end with AutoFocus beamforming technology. CE marking indicates compliance with European Union regulations governing medical devices, no matter where in the world they are manufactured, and enables free movement within the European market.
The cQuest Cicada product line is a scalable, full-featured ultrasound platform that offers a high level of flexibility and excellent image quality, enabling fast time to market for customers' end products. The Cicada product line begins with a 64-channel cQEngine hardware platform that is expandable to 256 channels.
The product complies with the essential requirements and exhibits the CE mark for the following equipment categories:
1) Industrial, scientific and medical equipment
2) Medical electrical equipment
By CE marking a product, a manufacturer declares that the product meets all the legal requirements for the CE marking which means that the product can be sold throughout the European Economic Area (EEA), the 28 member states of the EU and European Free Trade Association (EFTA) countries, Iceland, Norway and Liechtenstein.
For more information: www.cephasonics.com
July 30, 2024 
